Bellicum Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bellicum Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 76% to $1,500,000. Profit margin reached -1665%. Total operating expenses were $28,481,000.
Profit Margin
| 2013 | 1.94M | -7.96M | -410.62% |
|---|---|---|---|
| 2014 | 1.78M | -83.96M | -4717.13% |
| 2015 | 282K | -48.54M | -17215.6% |
| 2016 | 388K | -69.24M | -17845.62% |
| 2017 | 185K | -91.77M | -49610.27% |
| 2018 | 1.12M | -98.03M | -8753.21% |
| 2019 | 7.14M | -126.09M | -1765.25% |
| 2020 | 500K | -8.61M | -1723.8% |
| 2021 | 6.2M | -9.57M | -154.48% |
| 2022 | 1.5M | -24.97M | -1664.87% |
BLCM Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.5M | 6.2M | 500K | 7.14M | 1.12M | 185K | 388K | 282K | 1.78M | 1.94M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 1.5M | 6.2M | 500K | 7.14M | 1.12M | 185K | 388K | 282K | 1.78M | 1.94M |
Operating exp. | ||||||||||
Research and development | 22.76M | 23.57M | 39.05M | 64.53M | 71.15M | 65.66M | 51.26M | 33.56M | 11.00M | 7.04M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 28.48M | 30.58M | 54.58M | 94.50M | 96.58M | 87.57M | 68.76M | 49.41M | 16.40M | 9.86M |
Operating income | -26.98M | -24.86M | -51.69M | -87.36M | -95.46M | -87.38M | -68.38M | -49.13M | -57.83M | -7.92M |
Other income (expenses), net | 2.01M | 15.16M | -10.11M | -25.11M | -10K | -4.39M | -10K | 587K | -26.12M | -46.79K |
Income before tax | -24.97M | -9.70M | -7.72M | -112.47M | -98.03M | -91.77M | -69.24M | -48.54M | -83.96M | -7.96M |
Income tax expense | 2K | -127K | 897K | 13.61M | 1.62M | 3.67M | -1.45M | 12K | 1.08M | 3.92K |
Net income | -24.97M | -9.57M | -8.61M | -126.09M | -98.03M | -91.77M | -69.24M | -48.54M | -83.96M | -7.96M |
Earnings per share | ||||||||||
Basic EPS | -0.81 | -0.83 | -1.5 | -26.92 | -24.37 | -28.94 | -25.69 | -18.43 | -33.47 | -8.11 |
Diluted EPS | -0.81 | -0.83 | -1.5 | -26.92 | -24.37 | -28.94 | -25.69 | -18.43 | -33.47 | -8.11 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |